Bitte verwenden Sie diesen Link, um diese Publikation zu zitieren, oder auf sie als Internetquelle zu verweisen: https://hdl.handle.net/10419/284705 
Erscheinungsjahr: 
2024
Schriftenreihe/Nr.: 
SWP Comment No. 5/2024
Verlag: 
Stiftung Wissenschaft und Politik (SWP), Berlin
Zusammenfassung: 
The European Union's (EU) Global Health Strategy calls for open and strategic autonomy in the field of pharmaceuticals, which would lead to the redesign of EU global supply and value chains as well as trade relations. As the EU and Germany are seeking to diversify their trade partners, the Mercosur countries offer latent potential. Mercosur is the name of the South American trade bloc consisting of Argentina, Brazil, Paraguay and Uruguay, with Venezuela's membership currently suspended. The associate states of the bloc are Chile, Peru, Colombia, Ecuador, Guyana and Suriname. Bolivia is currently awaiting final approval to become a full member of the bloc.
Schlagwörter: 
pharmaceutical supply chains
Mercosur countries
EU's Global Health Strategy
Argentina
Brazil
Paraguay
Uruguay
Chile
Peru
Colombia
Ecuador
Guyana
Suriname
Bolivia
free trade agreement (FTA)
European Medicines Agency (EMA)
Health Emergency Preparedness and Response Authority (HERA)
Persistent Identifier der Erstveröffentlichung: 
Dokumentart: 
Research Report

Datei(en):
Datei
Größe
418.31 kB





Publikationen in EconStor sind urheberrechtlich geschützt.